Patient-Reported Outcomes from Patients with Waldenstrom Macroglobulinemia Treated with Ibrutinib-Rituximab: Results from iNNOVATE Study

被引：0

作者：

Matous, Jeffrey V. ^{[1
]}

Tedeschi, Alessandra ^{[2
]}

Dimopoulos, Meletios A. ^{[3
]}

Trotman, Judith ^{[4
]}

Garcia-Sanz, Ramon ^{[5
]}

Macdonald, David ^{[6
]}

Mahe, Beatrice ^{[7
]}

Herbaux, Charles ^{[8
]}

Heffner, Leonard ^{[9
]}

Tam, Constantine S. ^{[10
,11
,12
]}

Varettoni, Marzia ^{[13
]}

Palomba, M. Lia ^{[14
]}

Shustik, Chaim ^{[15
]}

Kastritis, Efstathios ^{[3
]}

Treon, Steven P. ^{[16
]}

Li, Jianling ^{[17
]}

Poulsen, Erik G. ^{[17
]}

Hauns, Bernhard ^{[17
]}

Buske, Christian ^{[18
]}

Leblond, Veronique ^{[19
]}

机构：

[1] Colorado Blood Canc Inst, Denver, CO USA

[2] ASST Grande Osped Metropolitano Niguarda, Milan, Italy

[3] Univ Athens, Sch Med, Athens, Greece

[4] Univ Sydney, Concord Hosp, Sydney, NSW, Australia

[5] Hosp Univ Salamanca, Salamanca, Spain

[6] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada

[7] CHU Nantes, Nantes, France

[8] Ctr Hosp Reg Univ Lille, Inst Hematol Transfus, Lille, France

[9] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[10] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[11] St Vincents Hosp, Melbourne, Vic, Australia

[12] Univ Melbourne, Melbourne, Vic, Australia

[13] Fdn IRCCS Policlin San Matteo, Pavia, Italy

[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[15] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Montreal, PQ, Canada

[16] Dana Farber Canc Inst, Boston, MA 02115 USA

[17] Pharmacyclics LLC, Sunnyvale, CA USA

[18] Univ Hosp Ulm, Ulm, Germany

[19] Sorbonne Univ Paris, Hop Pitie Salpetriere, AP HP, Paris, France

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-019

引用

下载

页码：S14 / S15

页数：2

共 50 条

[21] IMPROVED PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ABATACEPT: RESULTS FROM A PHASE III TRIAL
Strand, V.
Alemao, E.
Lehman, T.
Johnsen, A.
Banerjee, S.
Ahmad, H.
Mease, P.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 687 - 687
[22] Improved Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Abatacept: Results from a Phase III Trial
Strand, Vibeke
Alemao, E.
Lehman, T.
Johnsen, A.
Banerjee, S.
Ahmad, H. A.
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[23] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
Vibeke Strand
Evo Alemao
Thomas Lehman
Alyssa Johnsen
Subhashis Banerjee
Harris A. Ahmad
Philip J. Mease
Arthritis Research & Therapy, 20
[24] Efficacy of Ibrutinib-Rituximab versus Real World (RW) Treatments for Patients with Waldenstrom's Macroglobulinemia (WM): Adjusted Comparison of iNNOVATIE and the Lyon-Sud RW Database
Karlin, Lionel
Besson, Herve
Tapprich, Christoph
Garside, Jamie
Salles, Gilles
BLOOD, 2018, 132
[25] Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study
Mesa, Ruben A.
Harrison, Claire
Palmer, Jeanne M.
Gupta, Vikas
Mclornan, Donal P.
Mcmullin, Mary Frances
Kiladjian, Jean-Jacques
Foltz, Lynda
Platzbecker, Uwe
Fox, Maria Laura
Mead, Adam J.
Ross, David M.
Oh, Stephen T.
Perkins, Andrew Charles
Leahy, Michael F.
Kawashima, Jun
Ro, Sunhee
Donahue, Rafe
Gorsh, Boris
Deheshi, Samineh
Verstovsek, Srdan
HEMASPHERE, 2023, 7 (11): : E966
[26] Single-agent Ibrutinib is efficacious and well tolerated in Rituximab-refractory patients with Waldenstrom's Macroglobulinemia (WM): Initial results from an international, multicenter, open-label phase 3 substudy (INNOVATE™)
Buske, C.
Trotman, J.
Tedeschi, A.
Matous, J., V
Macdonald, D.
Tam, C.
Toumilhac, O.
Ma, S.
Oriol, A.
Heffner, L. T.
Shustik, C.
Garcia-Sanz, R.
Cornell, R. F.
Fernandez de Larrea, C.
Castillo, J. J.
Granell, M.
Kyrtsonis, M-C
Leblond, V
Symeonidis, A.
Singh, P.
Li, J.
Graef, T.
Bilotti, E.
Treon, S.
Dimopoulos, M. A.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 119 - 119
[27] Patient-reported Outcomes and Quality of Life in Patients with Rheumatoid Arthritis Treated with GP2015: Final Results from a Realworld Study
Askari, Ayman
Schmalzing, Marc
Kellner, Herbert
Ortega-Castro, Rafaela
Perez-Coleman, Julio Cesar Vazquez
Rosario, Foti
Jeka, Slawomir
Haraoui, Boulos
Allanore, Yannick
Rahman, Masiur
Furlan, Fabricio
Hachaichi, Sohaib
Sheeran, Tom
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 353 - 354
[28] PREDICTORS OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS TREATED PREVENTIVELY WITH RITUXIMAB: A PROSPECTIVE STUDY USING ULTRASOUND AND PATIENT-REPORTED OUTCOMES
Ismajli, Mediola
Leandro, Maria
RHEUMATOLOGY, 2017, 56 : 143 - 143
[29] Patient-Reported Outcomes from a Canadian Study of Patients Taking Methotrexate and Etanercept
Thorne, J. Carter
Keystone, Edward C.
Pope, Janet E.
Poulin-Costello, Melanie
Phan-Chronis, Krystene
Haraoui, Boulos
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S212 - S212
[30] Patient-reported outcomes and burden in resistant and refractory migraine: results from the REFINE study
Ratti, S.
Caponnetto, V.
Ornello, R.
Rosignoli, C.
De Santis, F.
Braschinsky, M.
Gentile, M.
Gil-Gouveia, R.
Lampl, C.
Martelletti, P.
Mazzanti, C.
Mitsikostas, D.
Munoz-Vendrell, A.
Oliveira, R.
Ozge, A.
Martins, I. Pavao
Pozo-Rosich, P.
Prudenzano, M.
Ryliskiene, K.
del Rio, M. Sancez
Vainauskiene, J.
Vernieri, F.
Waliszewska-Prosol, M.
Katsarava, Z.
Sacco, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 594 - 594

← 1 2 3 4 5 →